Literature DB >> 1991716

Mutagenic frequencies of site-specifically located O6-methylguanine in wild-type Escherichia coli and in a strain deficient in ada-methyltransferase.

S C Rossi1, M D Topal.   

Abstract

The adaptive response of Escherichia coli involves protection of the cells against the toxic and mutagenic consequences of exposure to high doses of a methylating agent by prior exposure to low doses of the agent. Ada protein, a major repair activity for O6-methylguanine, is activated to positively control the adaptive response; O6-methylguanine is one of the major mutagenic lesions produced by methylating agents. We investigated the mutation frequency of wild-type Escherichia coli and strains containing the ada-5 mutation in response to site-specifically synthesized O6-methylguanine under conditions in which the adaptive response was not induced. Site-directed mutagenesis and oligonucleotide self-selection techniques were used to isolate the progeny of M13mp18 DNAs constructed to contain O6-methylguanine at any of eight different positions. The progeny were isolated from E. coli strains isogeneic except for deficiency in Ada-methyltransferase repair, UvrABC excision repair, or both. The resulting O6-methylguanine mutation levels at each position were determined by using differential oligonucleotide hybridization. We found that the wild type had up to a 2.6-fold higher mutation frequency than ada-5 mutants. In addition, the mutation frequency varied with the position of the O6-methylguanine in the DNA in the wild type but not in ada-5 mutants; O6-methylguanine lesions at the 5' ends of runs of consecutive guanines gave the highest mutation frequencies. Determination of the mutation frequency of O6-methylguanine in wild-type and mutS cells showed that mismatch repair can affect O6-methylguanine mutation levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991716      PMCID: PMC207243          DOI: 10.1128/jb.173.3.1201-1207.1991

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  29 in total

1.  Calcium-dependent bacteriophage DNA infection.

Authors:  M Mandel; A Higa
Journal:  J Mol Biol       Date:  1970-10-14       Impact factor: 5.469

2.  Possible relevance of O-6 alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides.

Authors:  A Loveless
Journal:  Nature       Date:  1969-07-12       Impact factor: 49.962

Review 3.  Mutational specificity in bacteria.

Authors:  J H Miller
Journal:  Annu Rev Genet       Date:  1983       Impact factor: 16.830

4.  Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents.

Authors:  A E Pegg
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

5.  Escherichia coli mutator mutants deficient in methylation-instructed DNA mismatch correction.

Authors:  B W Glickman; M Radman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

6.  Base-pairing properties of O6-methylguanine in template DNA during in vitro DNA replication.

Authors:  E T Snow; R S Foote; S Mitra
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

7.  Mechanism of mutagenesis by O6-methylguanine.

Authors:  J S Eadie; M Conrad; D Toorchen; M D Topal
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

8.  Mechanisms of chemical mutagenesis and carcinogenesis: effects on DNA replication of methylation at the O6-guanine position of dGTP.

Authors:  D Toorchen; M D Topal
Journal:  Carcinogenesis       Date:  1983-12       Impact factor: 4.944

9.  Active site and complete sequence of the suicidal methyltransferase that counters alkylation mutagenesis.

Authors:  B Demple; B Sedgwick; P Robins; N Totty; M D Waterfield; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 10.  Methyl-directed DNA mismatch correction.

Authors:  P Modrich
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.